triglyceride

green light go go ahead advance yes streetlight
Biotech

Marea rises toward phase 2b after posting cholesterol data

Marea linked its antibody to a 53% placebo-adjusted mean reduction in remnant cholesterol, positioning the biotech to enter phase 2b imminently.
Nick Paul Taylor May 7, 2025 8:25am
photo of a royal flush laid out on the poker table with chips scattered nearby

Arrowhead posts phase 3 data ahead of market clash with Ionis

Sep 3, 2024 9:27am
fence palisade wall defense fence gate fortress fort

Arrowhead RNAi med lowers triglycerides in phase 3

Jun 3, 2024 9:54am
arrow archer target

Arrowhead on target in lipid disorder as it pursues Ionis

Apr 8, 2024 9:37am
Krill

Acasti abandons omega-3 filing after 2nd phase 3 flop

Sep 1, 2020 9:20am
Pfizer sign

Akcea, Pfizer hit midphase goal, but data raise doubts

Jan 29, 2020 7:10am